List of works - David M. G. Halpin

A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD

scientific article published on 26 November 2020

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial

scientific article published on 04 July 2019

Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial

scientific article published on 09 July 2020

Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee

scientific article published on 01 January 2019

Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of the IMPACT Trial

scientific article published on 05 October 2020

Impact of comorbid conditions on asthmatic adults and children

scientific article published on 20 August 2020

InforMing the PAthway of COPD Treatment Single-Inhaler Triple Therapy (Fluticasone Furoate/ Umeclidinium/ Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium /Vilanterol in Patients With COPD: Analysis of the Western Europe and North

scientific article published on 05 November 2020

Misinterpretation of time-to-first event curves can lead to inappropriate treatment

scientific article published on 05 September 2019

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.

scientific article published on 18 April 2018

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients

scientific article published on 12 March 2020

Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis

scientific article published in 2023

Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients

scientific article published on 11 August 2021

Risk of Exacerbation and Pneumonia with Single Inhaler Triple Versus Dual Therapy in IMPACT

scientific article published on 27 October 2020

Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study

scientific article published on 09 July 2020

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial

scientific article published on 05 June 2020

Stand on the Same Side Against Covid – 19: Ics-Containing Products in Treatment Covid-19 Patients with Asthma and COPD

scholarly article published on Substantia in 2021

The Effect of Exacerbation History on Outcomes in the IMPACT Trial

scientific article published on 16 April 2020

The Effect of ICS Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study: A Randomized, Double-blind Multicenter Trial

scientific article published on 25 June 2020

Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT Trial

scientific article published on 17 November 2020

List of works by David M. G. Halpin